Editorial: finding the coeliacs – should everyone be screened?
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 12, Page 1717-1718, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 24, 2018 Category: Drugs & Pharmacology Authors: B. Lebwohl , P. H. R. Green Source Type: research

Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection —authors' reply
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 12, Page 1720-1721, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 24, 2018 Category: Drugs & Pharmacology Authors: L. ‐Y. Mak , M.‐F. Yuen Source Type: research

Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 12, Page 1719-1720, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 24, 2018 Category: Drugs & Pharmacology Authors: M. ‐L. Wang , E.‐Q. Chen , C.‐M. Tao , H. Tang Source Type: research

Outcomes of oesophageal self ‐dilation for patients with refractory benign oesophageal strictures
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 22, 2018 Category: Drugs & Pharmacology Authors: Y. Qin , D. B. Sunjaya , S. Myburgh , T. Sawas , D. A. Katzka , J. A. Alexander , M. Halland Source Type: research

Issue Information
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1425-1427, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Source Type: research

Editorial: chronic hepatitis B combination therapy —emerging success as proof‐of‐concept for future hepatitis B eradication?
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1560-1561, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: Q. M. Nhu , P. J. Pockros Source Type: research

Editorial: de novo inflammatory bowel disease following bariatric surgery —potential implications for research and clinical practice
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1539-1540, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: S. Alukaidey , N. Heerasing Source Type: research

Editorial: de novo inflammatory bowel disease following bariatric surgery —potential implications for research and clinical practice. Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1540-1540, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: R. Ungaro , J. ‐F. Colombel Source Type: research

Editorial: let's take a break from studying the PPI ‐fracture association—Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1544-1545, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: S. Torvinen ‐Kiiskinen , A.‐M. Tolppanen , M. Koponen , A. Tanskanen , J. Tiihonen , S. Hartikainen , H. Taipale Source Type: research

Editorial: measuring hypervigilance and anxiety in oesophageal disorders
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1559-1560, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: A. Patel , C. P. Gyawali Source Type: research

Editorial: an expert consensus for the management of chronic hepatitis B in Asian Americans —Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1542-1543, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: M. J. Tong , C. Q. Pan Source Type: research

Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1551-1552, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: P. Ingiliz , A. Canbay Source Type: research

Editorial: genotype 3 HCV —who still needs ribavirin in a pan‐genotypic era? Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1550-1551, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: J. von Felden , J. Vermehren , J. Schulze zur Wiesch , C. Sarrazin , S. Christensen Source Type: research

Editorial: genotype 3 HCV —who still needs ribavirin in a pan‐genotypic era?
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1548-1549, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: M. D. Sadler Source Type: research

Editorial: grey zone, a new area of interest in chronic hepatitis  B
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1547-1548, June 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: E. Ridruejo Source Type: research